cp 93129 has been researched along with cyclohexanol in 1 studies
| Studies (cp 93129) | Trials (cp 93129) | Recent Studies (post-2010) (cp 93129) | Studies (cyclohexanol) | Trials (cyclohexanol) | Recent Studies (post-2010) (cyclohexanol) |
|---|---|---|---|---|---|
| 109 | 0 | 11 | 4,548 | 691 | 1,355 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Béïque, J; Blier, P; de Montigny, C; Debonnel, G | 1 |
1 other study(ies) available for cp 93129 and cyclohexanol
| Article | Year |
|---|---|
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Topics: Adrenergic alpha-Agonists; Animals; Autoreceptors; Brimonidine Tartrate; Carrier Proteins; Cricetinae; Cyclohexanols; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Symporters; Time Factors; Tritium; Venlafaxine Hydrochloride | 2000 |